The FDA has approved a new drug called revumenib that can be taken orally to treat acute leukemia in patients 1 year or older. The drug will be marketed under the brand name Revuforj.

Nvidia helped pulled U.S. stock indexes higher on Tuesday after they stumbled in the morning on worries about escalations in ...

The widower of a Carle Place physician asked a Florida court to mandate the testing of leftovers, saying the allergens in ...

What to know about allegations against Matt Gaetz, new details in the reported testimony hack, and where he stands with ...

President-elect Trump is promising more government efficiency – but is money really being wasted on cats on treadmills?

After months of campaigning and waiting, consumers now know a little more of what they can expect 2025 to bring. A second ...

A man stabbed dead two men and a woman at three different locations within a two-and-a-half-hour span in New York City. Ramon ...

The Newcells aProximateTM near-physiological kidney transporter model provides cross-species comparison of drug handling.

Astellas Pharma (ALPMY) announced the Food and Drug Administration issued a Complete Response Letter regarding the supplemental new drug ...

Leaders of the new Rutgers School of Medicine (RSOM) have released a new mission, vision and values statement that ...

Tottenham announced they had “remastered” their brand identity. For anyone left confused by that phrase, don’t worry, you ...

Health care and tech innovation go hand in hand. From delivering steady streams of medication to speeding up treatment of ...